Updated experience from mosunetuzumab in multiple relapsed follicular lymphoma: Promising efficacy from a phase I trial Meeting Abstract


Authors: Assouline, S.; Kim, W. S.; Sehn, L. H.; Schuster, S. J.; Cheah, C. Y.; Nastoupil, L. J.; Shadman, M.; Yoon, S. S.; Matasar, M. J.; Diefenbach, C.; Gregory, G. P.; Bartlett, N. L.; Wei, M. C.; Doral, M. Y.; Yin, S.; Negricea, R.; Li, C. C.; Penuel, E.; Huang, H.; Budde, L. E.
Abstract Title: Updated experience from mosunetuzumab in multiple relapsed follicular lymphoma: Promising efficacy from a phase I trial
Meeting Title: 9th Annual Meeting of the Society of Hematologic Oncology (SOHO)
Keywords: follicular lymphoma; phase i; relapsed/refractory; ibcl; mosunetuzumab; heavily; pre-treated
Journal Title: Clinical Lymphoma, Myeloma and Leukemia
Volume: 21
Issue: Suppl. 1
Meeting Dates: 2021 Sep 8-11
Meeting Location: Virtual
ISSN: 2152-2650
Publisher: Elsevier Inc.  
Date Published: 2021-09-01
Start Page: S406
End Page: S407
Language: English
ACCESSION: WOS:000691910500354
PROVIDER: wos
DOI: 10.1016/s2152-2650(21)01916-9
Notes: Meeting Abstract: IBCL-373 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Matthew J Matasar
    289 Matasar